90 related articles for article (PubMed ID: 7707276)
1. Distant haemorrhagic effects in intra-arterial tissue plasminogen activator--the effect of a bolus dose.
Cripps NP; Ward AS
J R Nav Med Serv; 1994; 80(2):66-70. PubMed ID: 7707276
[TBL] [Abstract][Full Text] [Related]
2. A new intra arterial rt-PA dosage regimen in peripheral arterial occlusion: bolus followed by continuous infusion.
Juhan C; Haupert S; Miltgen G; Girard N; Dulac P
Thromb Haemost; 1991 May; 65(5):635. PubMed ID: 1908142
[No Abstract] [Full Text] [Related]
3. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
5. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
Ouriel K; Kandarpa K
J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
7. [Intra-arterial thrombolysis using rt-PA in peripheral arterial occlusions]].
Decrinis M; Pilger E; Stark G; Lafer M; Obernosterer A; Pieber D; Lammer J; Aschauer M
Vasa Suppl; 1991; 33():131. PubMed ID: 1788644
[No Abstract] [Full Text] [Related]
8. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
9. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy for arterial occlusion: a mixed blessing.
Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
[TBL] [Abstract][Full Text] [Related]
12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
13. [Local intra-arterial thrombolysis with low dosage rt-PA. Thrombolysis in arterial occlusive disease of the leg].
Weidauer T; Timmermann J
Fortschr Med; 1990 Dec; 108(36):700-2. PubMed ID: 2128294
[TBL] [Abstract][Full Text] [Related]
14. [Renal artery embolism treated by selective intra-arterial infusion of tissue plasminogen activator: report of 2 cases].
Inoue T; Iwamura H; Kanematsu A; Hiura M; Kakehi Y; Hashimura T
Hinyokika Kiyo; 1997 Sep; 43(9):655-9. PubMed ID: 9365846
[TBL] [Abstract][Full Text] [Related]
15. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
Enevoldsen MT; Rørdam P; Schroeder TV
Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
[TBL] [Abstract][Full Text] [Related]
16. Recanalization of chronic peripheral arterial occlusions by alternating intra-arterial rt-PA and PGE1.
Kröger K; Hwang I; Rudofsky G
Vasa; 1998 Feb; 27(1):20-3. PubMed ID: 9540428
[TBL] [Abstract][Full Text] [Related]
17. [Selective percutaneous transluminal thrombolytic therapy with rt-PA in central retinal artery occlusion].
Vulpius K; Höh H; Lange H; Maercker W; Rühle H
Ophthalmologe; 1996 Apr; 93(2):149-53. PubMed ID: 8652980
[TBL] [Abstract][Full Text] [Related]
18. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
19. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic therapy with tissue-type plasminogen activator].
Toma M; Yamaguchi T
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
